Clinical Trial Update: Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

View source ↗

Summary

Clinical trial update describing a Bristol-Myers Squibb-sponsored study to perform transgene assay testing on tumor samples from patients who previously receive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Abecma (idecabtagene vicleucel)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia | Status: RECRUITING